——On June 24, the three-day 23rd World Pharmaceutical Ingredients China Exhibition (CPHI China 2025) concluded successfully at the Shanghai New International Expo Center. As a leading domestic developer and manufacturer of food-grade and health supplement-grade amino acid raw materials, Shanghai Xutai Bio-Technology Co., Ltd. (hereinafter referred to as “Shanghai Xutai) gained widespread attention from customer from both home and abroad at the exhibition through its exceptional product quality and professional technical services, further solidifying the company's brand influence in the global pharmaceutical raw materials market.

During the exhibition, Shanghai Xutai's booth (booth number: E1G52) attracted many industry experts, purchasers, and partners to stick around booth and communicate. The company team, with its deep industry experience and professional skills, gave customers a comprehensive introduction to its food-grade and health product-grade amino acid raw material series products, and highlighted the company's core strengths in quality control, research and development innovation, and customized services.

It is worth mentioning that even before the exhibition ended, Shanghai Xutai had already received inquiries and cooperation proposals from many companies in North America, Europe, Southeast Asia, and China, covering popular products such as glutamine, arginine, and branched-chain amino acids (BCAA). This positive feedback not only reflects the market's high recognition of Shanghai Xutai's products, but also lays a solid foundation for the company to further expand into the international et. mark

Through this exhibition platform, the Shanghai Xutai team engaged in in-depth exchanges with global customers, accurately identifying the different needs of different regions in terms of quality standards, packaging specifications, and price ranges for pharmaceutical excipients. For example, European and American customers place greater emphasis on organic certification and sustainable production, while the Southeast Asian market demonstrates a significant demand for cost-effective small-sized packaging. These first-hand insights will provide crucial reference for the company to optimize its product structure and formulate targeted market strategies.

The general manager of Shanghai Xutai said at the exhibition: “CPHI China is a benchmark event for the pharmaceutical raw materials industry in Asia, and participating in this exhibition is a milestone for us. Through this platform, we have not only demonstrated the technical strength of Chinese amino acid raw material companies to global customers, but also clarified international market development trends through face-to-face communication. In the future, we will continue to increase investment in research and development, deepen cooperation with customers both home and abroad, and promote high-quality Chinese amino acid raw materials to broader markets.”

The successful participation in this exhibition marks a key step forward for Shanghai Xutai in its internationalization strategy. The company will use this exhibition as an opportunity to further strengthen technological innovation and service quality, thereby contributing to the high-quality development of the global pharmaceutical and healthcare industry.